Pharmacokinetic-guided Dosing of Emicizumab

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(8 sites)

Netherlands

Radboud University Medical Center, Nijmegen, Gelderland

Maastricht University Medical Center, Maastricht, Limburg

Amsterdam University Medical Center, Amsterdam, North Holland

Leids Universitair Medisch Centrum, Leiden, South Holland

Erasmus University Medical Center, Rotterdam, South Holland

HagaZiekenhuis, The Hague, South Holland

University Medical Center Groningen, Groningen

University Medical Center Utrecht, Utrecht